Alexander Vos, CEO

April 20 | 11:45am | Gaudi 2 Ballroom

Amsterdam, Netherlands


In-Person Presentation

VectorY is developing next generation gene therapies by combining antibody know-how with AAV-based gene therapy technologies focused on neurodegenerative and neuromuscular disorders.

By using this website you agree to accept our Privacy Policy and Terms & Conditions